Sponsored by:

Molecular Imaging: Page 469

Philips, Bioscan partner on NanoSPECT marketing
By AuntMinnie.com staff writers
Philips Medical Systems has signed an agreement giving it the rights to co-market and co-distribute molecular imaging developer Bioscan's NanoSPECT and NanoSPECT/CT devices.
January 1, 2007
ART, GE extend eXplore Optix pact
By AuntMinnie.com staff writers
Canadian optical molecular imaging developer ART Advanced Research Technologies (ART) and GE Healthcare of Chalfont St. Giles, U.K., have extended their current agreement for GE to be the exclusive worldwide distributor of ART's eXplore Optix preclinical optical molecular imaging system.
December 21, 2006
Trial date set for IBA, Optivus dispute
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Application (IBA) is reporting that a trial date has been set in Los Angeles on the remaining claims asserted against IBA by Optivus Technology of Loma Linda, CA, and Loma Linda University Medical Center.
December 20, 2006
GE installs first Discovery STE in Canada
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K,. has completed the first installation of its Discovery STE PET/CT technology in Canada.
December 20, 2006
Siemens, UCLA to test Alzheimer's PET agent
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, announced today that it plans to begin clinical trials in collaboration with the University of California, Los Angeles, on a new biomarker based on PET technology that could potentially identify Alzheimer's disease before the onset of symptoms.
December 20, 2006
Mayo team refines scintimammography camera design
By Brian Casey
December 18, 2006
Solid-state dual-head camera supercharges molecular breast imaging
By Jonathan S. Batchelor
Molecular breast imaging's potential for detecting malignant tumors has been constrained by different factors, such as the limitation of conventional scintimammography with Tc-99m sestamibi in detecting smaller malignant tumors. But Mayo Clinic researchers may have overcome these drawbacks by developing a solid-state dual-head gamma camera for breast imaging.
December 18, 2006
PET reveals limbic dysfunction in mesial temporal lobe epilepsy
By Paula Moyer
Patients with mesial temporal lobe epilepsy (MTLE) who have an abnormal odor perception may have widespread limbic dysfunction, according to a presentation by Swedish investigators at the North American Regional Epilepsy Congress in San Diego earlier this month.
December 18, 2006
MDS Nordion shows Q4 revenue downturn, year-end upturn
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion, a division of Toronto-based MDS, reported a decrease in revenues for its fiscal 2006 fourth quarter (end-October 31), although the fiscal year showed positive growth.
December 13, 2006
University of Ottawa Heart Institute gets PET grant
By AuntMinnie.com staff writers
The University of Ottawa Heart Institute (UOHI) was awarded a total of more than $10 million ($8.65 million U.S.) by the Canada Foundation for Innovation (CFI) to identify and treat the causes of coronary artery disease.
December 13, 2006
ART gets Health Canada approval for SoftScan
By AuntMinnie.com staff writers
Canadian optical molecular imaging developer ART Advanced Research Technologies (ART) reported that it has received clearance from Health Canada to commercialize its SoftScan optical breast imaging device.
December 13, 2006
IBA to supply radiopharmaceuticals to Spain
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Applications (IBA) has been named by the regional health authorities in the Spanish region of Andalusia as its exclusive supplier of FDG and other radiopharmaceuticals.
December 13, 2006
Previous Page
Page 469 of 611
Next Page